Carelight Weartech – powered by OPM

Carelight is redefining what’s possible in patient monitoring. A UK-based health technology company with a global outlook, we are building the next generation of medical-grade wearables to transform how clinicians and patients detect, monitor and manage disease.

Backed by more than 15 years of research and clinical expertise, our patented Opto-Physiological Monitoring (OPM) platform follows the patient journey from hospital to home, giving clinicians real-time insight and empowering people to recover where they heal best.

Today, our focus is on safer recovery and better outcomes. Carelight’s wearable devices continuously track vital signs such as heart rate, breathing and blood oxygen, all without the need for constant in-person checks. This means patients can leave hospital sooner, recover with confidence at home, and clinicians can make informed decisions based on accurate, continuous data.

Our Weartech portfolio is designed to fit seamlessly into different care environments and patient needs. The wrist device is our first form factor, with future innovations including chest patches, neonatal devices and forehead sensors. Each device is powered by our OPM platform, providing accurate, non-invasive monitoring across diverse populations. Importantly, Carelight technology delivers consistent accuracy in the real world – across different lifestyles, characteristics and skin tones – addressing long-standing problems in patient monitoring

Looking ahead, our ambition is bold: to detect disease earlier than ever before. Our initial focus is cardiopulmonary health, but our platform has potential applications across multiple chronic and acute conditions. By advancing preventative care, we aim to help clinicians act sooner, reduce healthcare costs and ultimately change the way the world experiences healthcare.

Everything we create is grounded in science, strengthened by collaborations with trusted partners and driven by a relentless commitment to innovation. Our work is supported by published research, clinical validation and an expanding pipeline of regulatory milestones, including CE marking and FDA clearance.

From acute care to early detection, Carelight is leading the charge towards a future where location is no barrier to world-class healthcare. Whether in the hospital, the home, or in specialist care environments, our vision is the same: Enabling earlier diagnosis and real time management of cardiovascular and pulmonary disease.